AHAdam P. Hill

Adam P. Hill

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Adam P. Hill has a total of 260 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Wireless and contactless biomechanic well plate for monitoring cardiac organoid and 3D-tissue contraction

    by Chi Cong Nguyen, Jordan Thorpe, Tran Bach Dang, Azadeh Zahabi, Quang Anh Nguyen, Sinuo Zhao, Nhat Minh Doan, Michael A. Listyawan, Hongru Chen, Thanh Vinh Nguyen, et al.

    Although animal models underpin cardiovascular research, their limited ability to correctly reproduce human-specific cardiac physiology has accelerated the adoption of three-dimensional (3D) human cardiac organoids and engineered heart tissues. Quantitative tracking of the mechanical behaviour of these 3D cultures provides critical insights into contractile dynamics, functional performance, disease phenotypes and pharmacological responses. However, real-time measurement of these properties remains challenging because of complex 3D geometries and subtle forces generated during contraction. Existing approaches are further constrained by low-throughput, arising from requirements for on-sensor cell cultivation, mechanical clamping or labour-intensive optical analysis. Here we introduce a bio-inspired, wireless platform that integrates ultrasensitive silicon cantilevers with a microscale liquid membrane via air-mediated coupling. Air-pressure changes generated by membrane deflection convert organoid contractility into cantilever bending, enabling non-contact, precise and high-throughput quantification of submillinewton contraction forces across multiple 3D cardiac tissues. By eliminating key experimental constraints, this system establishes a scalable framework for drug screening, electrical stimulation studies and disease modelling in human-relevant cardiac platforms.


  • Autonomic Nervous System Dysregulation as a Driver of Atrial Fibrillation: Pathways, Modulators and Therapies

    by Sutapa Saha, Jordan Thorpe, Adam P. Hill

    Cardiac arrhythmias affect 1–5% of the global population, with atrial fibrillation (AF) being the most common and clinically relevant. While AF is traditionally linked to electrical and structural remodelling of the atria, growing evidence highlights a critical yet underexplored contributor: dysfunction of the autonomic nervous system (ANS). The ANS regulates heart rate and rhythm through sympathetic and parasympathetic inputs, and its imbalance can initiate and sustain AF by promoting ectopic activity, shortening refractory periods, and enhancing re-entry circuits. Autonomic dysregulation is further impacted by lifestyle and environmental influences. Excessive alcohol intake, chronic stress, sleep deprivation, and extreme physical exertion have all been shown to modulate autonomic activity and elevate the risk of AF. Additionally, social determinants such as socioeconomic status and healthcare access indirectly influence AF susceptibility through chronic activation of neuro-cardiac stress pathways. Mechanistically, emerging research implicates sympathetic hyperinnervation, neuro-inflammation, and dysfunction of intrinsic cardiac ganglionated plexi as key contributors to arrhythmogenic remodelling. However, current animal models often fail to capture the complexity of human neuro-cardiac interactions due to species-specific differences in cardiac anatomy, innervation patterns, and immune responses. Human induced pluripotent stem cell (iPSC)-derived models offer an alternative, patient-specific platform to study ANS-driven mechanisms in AF. This review focuses on the role of the ANS in AF pathophysiology, examining the cellular and molecular mechanisms by which autonomic dysregulation promotes arrhythmia. We explore current therapeutic interventions of autonomic driven AF and discuss the potential of new models to improve mechanistic insight and therapeutic development.

  • Open Access

    MultiECGNet: Evaluation of a Deep-Learning Ensemble Method for Image-Based 12-Lead Electrocardiographic Detection of Atrial Fibrillation

    by George Parker, Justin Phan, Nigel H. Lovell, Rajesh N. Subbiah, Jamie I. Vandenberg, Adam P. Hill, Ahmadreza Argha

  • Open Access

    Protocol-dependent cardiomyocyte states determine disease modelling capacity of human iPSCs

    by Sophie Shen, Clarissa Tan, Yuanzhao Cao, Chris Siu Yeung Chow, Dalia Mizikovsky, Janice Reid, Steve Dingwall, Andrew Prowse, Yuliangzi Sun, Zhixuan Wu, et al.

    Human induced pluripotent stem cell–derived cardiomyocytes (iPSC-CMs) are widely used to model cardiovascular disease, yet numerous differentiation protocols generate cardiomyocytes with heterogeneous molecular and functional properties, complicating experimental design. Here we systematically compare sixteen commonly used cardiomyocyte differentiation protocols and characterize their resulting cell states using single-nucleus RNA sequencing, functional phenotyping and computational integration with human genetic data. Despite similar cardiomyocyte yields, protocols produced distinct transcriptional programs, subtype compositions and physiological properties. By integrating protocol-specific gene expression signatures with genome-wide association studies of cardiovascular traits, we identify cardiomyocyte states enriched for genetic architectures underlying specific diseases. These analyses accurately predict protocols most suitable for modelling particular disease contexts, including electrophysiological defects associated with Brugada syndrome and metabolic vulnerability relevant to myocardial infarction. Our results demonstrate that differentiation protocols encode biologically distinct cardiomyocyte states with differential disease relevance and establish a framework for aligning stem-cell differentiation strategies with human complex trait genetics to guide model selection. This approach enables rational design of iPSC-based disease models and highlights how population-scale genetic data can inform experimental systems in stem cell biology.

  • Open Access

    Correction: Development of a robust induced pluripotent stem cell atrial cardiomyocyte differentiation protocol to model atrial arrhythmia

    by Jordan Thorpe, Matthew D. Perry, Osvaldo Contreras, Emily Hurley, George Parker, Richard P. Harvey, Adam P. Hill, Jamie I. Vandenberg

  • Open Access

    Robotic Handling Preserves Induced Pluripotent Stem Cell Derived Vascular Smooth Muscle Cells Differentiation using a Weekend-free, Automatable, Low-variability, Low-cost (WALL) Protocol

    by Monique Bax, Jeya Ramalingam, Valentin Romanov, Muhammad A Alsherbiny, Keerat Junday, Jordan Thorpe, Emily Hurley, Melanie Lim, Ingrid Tarr, Stephanie Hesselson, et al.

    Vascular disease modeling and tissue engineering require scalable, efficient, and reproducible methods for differentiating cells, however no studies have validated whether automation, essential for scale-up, preserves differentiation quality in cells. Here, we developed a differentiation protocol for induced pluripotent stem cell (iPSC)-derived vascular smooth muscle cells (iVSMCs) that is applicable to both manual, and automated robotic culture. iPSC lines generated from male and female donors across various ages were used to optimize the generation of iVSMCs. iVSMCs had consistent morphology and protein expression was largely similar to primary VSMCs, including expression of myosin heavy chain-11 (MYH11), α-smooth muscle actin (α-SMA), transgelin (TAGLN) and calponin (CNN1). Functionally, these iVSMCs could respond to the vasoconstrictor carbachol. Coupling this protocol with an automated Hamilton liquid-handling robotics system allowed the generation of iVSMCs in large quantities, morphologically similar to manually differentiated iVSMCs. Comparative proteomic analysis confirmed protein expression did not differ between automated and manual differentiation methods. Automation markedly reduced manual labor and facilitated increased production without sacrificing cell quality. This study demonstrates the feasibility of automating iVSMC differentiation, marking a significant step towards scalable VSMC manufacturing for three-dimensional applications, and for the ever-growing demands of organoid and tissue engineering applications. Statement of significance: The rapidly expanding fields of tissue engineering and high-throughput disease modeling require large quantities of viable cells, making automation essential. Robotic liquid handling systems are increasingly employed for generating large quantities of induced pluripotent stem cell (iPSC)-derived cells, requiring the development of scalable protocols. No studies have yet evaluated whether the use of robotic liquid handling alters the differentiation of cells compared to traditional manual handling. Here, we report a scalable differentiation protocol that robustly generates iPSC-derived VSMCs (iVSMCs) from a cohort of female and male donors of varying age (n=5 lines). We demonstrate for the first time that iVSMCs, differentiated through an automated robotic pipeline, had no significant differences in morphological or proteomic phenotype compared to manual differentiation. The ability to automate this protocol facilitates robust and reproducible differentiation of large quantities of iVSMC, setting a precedent for the application of automation in generating iPSC-derived cells. Graphical

  • Open Access

    KICA: A MATLAB package for high-throughput analysis of calcium and voltage imaging data from cardiac cells

    by Satya N.V Arjunan, Anton Shpak, George W. Parker, Adam P. Hill

    Background Fluorescent time-series data reporting cellular calcium homeostasis and membrane voltage are common measures of cardiac physiology with widespread utility in areas such as disease modelling and drug screening. The growth in the use of high-throughput platforms in this area has resulted in a significantly increased requirement for automated quality control, processing and data analysis. Methods To support this, we developed a MATLAB package, KICA (Kinetic Imaging Cytometry Analyser), which rapidly processes and analyzes large-scale fluorescent time-series data. The KICA signal processing implementation applies denoising, drift removal, calculation of signal-to-noise ratio (SNR), and pulse/beat detection, along with subsequent pulse analysis including peak/upstroke detection, calculation of activation times, rise and fall times, beat rates, and parameters related to pulse width (action potential or calcium transient durations). The output includes quality-controlled data, summary statistics, and figures for individual cells. Results KICA includes example input datasets (CSV files) and a user guide to facilitate rapid understanding and verification of functionality. Users can process these examples, setting key parameters for signal type, detection thresholds, and duration calculations, to generate Excel reports summarising key pulse characteristics such as action potential duration (APD), peak amplitude, and SNR, alongside figures visualising the processed signals and detected beats for interpretation. KICA is optimised for parallel operation and achieves nearly linear speedup in computational time, demonstrating its capability for efficient high-throughput analysis. Conclusions KICA provides a robust and efficient automated solution, streamlining the analysis of large kinetic imaging cytometry datasets and supporting high-throughput research in cardiac physiology and drug screening.

  • Open Access

    MultiECGNet: A novel deep learning-based multi-format ensemble method for image-based electrocardiographic diagnosis of atrial fibrillation

    by Justin Phan, George Parker, Nigel Lovell, Rajesh N Subbiah, Jamie I Vandenberg, Adam P. Hill, Ahmadreza Argha

    Aim To evaluate the performance of an ensemble classifier, MultiECGNet, using multi-format electrocardiographic (ECG) images for the diagnosis of atrial fibrillation (AF), and to compare its performance with a signal-based deep learning model. Methods An ensemble of ECG classifiers was developed using four models derived by truncating the pre-trained EfficientNet B3 model at different feature extraction layers. Transfer learning was employed to train the ensemble on the publicly available PTB-XL dataset for AF detection. External validation was performed using the Chinese Physiological Society Signal Challenge 2018 dataset. ECG samples were converted into two image formats (2x6 and 4x3), and performance was evaluated across same-format, cross-format, and mixed-format classification tasks. Results The ensemble classifier detected AF in the external validation dataset with an accuracy of 0.95 and F1 score of 0.87, which was comparable to a signal-based model (F1-score: 0.87 vs 0.83) and outperformed a single EfficientNet-B3 model (F1-score: 0.87 vs 0.71). Training on one ECG format and testing on a different format resulted in reduced performance (F1 score: 0.66-0.71). However, training on a dataset containing a balanced mix of both formats improved performance compared to same-format training alone (F1-score: 0.86 vs 0.87). Conclusion The proposed image-based ensemble classifier demonstrated comparable performance to a strong signal-based model for AF detection. While cross-format generalization posed a challenge, incorporating multiple ECG formats during training mitigated this limitation and improved model robustness.

  • Open Access

    Independent derivations of the axis of arrhythmia for predicting drug‐induced torsades de pointes

    by Stewart Heitmann, Jamie I. Vandenberg, Adam P. Hill

    Background and Purpose: Torsades de pointes is a potentially lethal ventricular arrhythmia that can be induced by many classes of drugs. The risk for a given drug depends upon the combination of cardiac ion channels that it targets. The axis of arrhythmia quantifies that risk. It is a conceptual line in the electrophysiology that describes the most potent combination of ion channel blocks that is theoretically possible. The axis thus serves as a convenient yardstick for quantifying the pro‐arrhythmic risk of real drugs. Until now, the axis of arrhythmia has only been derived from biophysical computer simulations.Experimental Approach: Here, we derive the axis directly from the response profiles of four key cardiac ion currents and using publicly available drug datasets. The new method provides an independent line of evidence for the axis of arrhythmia.Key Results: Following a process of step‐wise reduction, the two methods were found to converge to identical estimates of the axis in two ion currents and . The final estimate of the axis predicted the pro‐arrhythmic risk of the drugs (n=109) with 89.9% to 91.7% accuracy.Conclusion and Implications: The axis of arrhythmia offers a practical method for predicting the pro‐arrhythmic risk of novel drugs prior to clinical trials, without the need for drug‐specific computer simulations. It is the only metric of pro‐arrhythmic risk that has been derived from both a biophysical model and a statistical model. It thus combines the benefits of biophysical interpretation and computational efficiency when assessing torsadogenic risk.


  • Open Access

    Complementarity and integration of animal and in vitro non-animal pre-clinical model systems– an Australian perspective

    by Ruth M. Arkell, Ernst J. Wolvetang, Twishi Gulati, James E. Hennessy, Adam P. Hill, Thierry Jardé, Andrew J. Kueh, Paul Q. Thomas, Louise N. Winteringham, Michael S. Dobbie

    Recent advances in the development of pre-clinical models based on non-animal technologies (NATs) have stimulated expectations that the use of animals in research may soon be phased out. The true value of innovations in NATs and their applications lies, however, in enabling an expanded and integrated portfolio of complementary animal and non-animal model systems to improve the accuracy and efficiency of pre-clinical research and therapeutic development. The term NATs covers a range of techniques spanning in silico, cell free, organ-on-chip as well as in vitro techniques including three-dimensional cell culture models termed organoids. Of these, in vitro systems are currently the most broadly used in biomedicine laboratories and are the first NATs for which Australia has invested in nationwide support. The focus of this commentary is the importance of understanding the strengths and limitations of in vitro and animal models such that an integrated portfolio of complementary genetic models continues to evolve to best support pre-clinical research and therapeutic development pipelines.